SS 28 - GU 6: Revelations in Renal Radiotherapy

Presentations

• 05:00pm - 06:00pm PT

  GU 6: Revelations in Renal Radiotherapy

  Speaker: Himanshu Nagar, MD, MS - Memorial Sloan Kettering Cancer Center, New York
• 05:00pm - 06:00pm PT

  GU 6: Revelations in Renal Radiotherapy

  Speaker: Adam Olson, MD, MS - UPMC Hillman Cancer Center, Pittsburgh
• 05:00pm - 05:10pm PT

  Stereotactic Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer: Final Results of a Phase IIb Trial

  Speaker: Ryan Assadi, DO, MS - UTSW, Dallas
• 05:10pm - 05:20pm PT

  Ultra-Hypofractionated Stereotactic Ablative Body Radiotherapy (SABR) for Primary Renal Cell Carcinoma: Pooled Outcomes from the FASTRACK and FASTRACK II Clinical Trials

  Speaker: Shankar Siva, PhD, MBBS, FRANZCR - Peter MacCallum Cancer Centre, Parkville
• 05:20pm - 05:30pm PT

  Long-Term Follow-up Results after Stereotactic Body Radiotherapy for Primary Renal Cell Carcinoma: A Prospective Multicenter Phase 2 Trial

  Speaker: Hiroshi Onishi, MD, PhD - University of Yamanashi, Chuo-shi 409-3898
• 05:30pm - 05:40pm PT

  Stereotactic Body Radiation Therapy (SBRT) for Renal Tumors: A Prospective Phase II Study

  Speaker: Katelyn Wang, - Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto
• 05:40pm - 05:50pm PT

  Neoadjuvant Pembrolizumab and Stereotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma (NAPSTER): A Phase II Randomized Clinical Trial

  Speaker: Muhammad Ali, MBBS - Peter MacCallum Cancer Centre, Melbourne 8006
• 05:50pm - 06:00pm PT

  Discussant

  Speaker: Chad Tang, MD - MD Anderson Cancer Center, Houston